As many advocates are pushing for decriminalization and completely descheduling cannabis at the federal level, one Republican congressman is pushing to simply downgrade cannabis from schedule I to schedule III, which would allow for research to move forward at a faster pace and provide several other perks.
Rep. Greg Steube (R-Florida) reintroduced a bill as H.R. 610 or the Marijuana 1-to-3 Act on Jan. 27, about four years after filing a similar bill previously, along with seven other bills, according to a press release.
The bill would direct the Attorney General of the United States to amend the Controlled Substances Act (CSA) to move cannabis from schedule I to schedule III of the Act—within 60 days of the bill’s enactment.
The bill doesn’t go as far as others that would end the federal prohibition of cannabis via decriminalization or other routes. However, the bill would protect federal employees who consume cannabis, as only Schedule I or II substances are prohibited. It would also free cannabis businesses affected by Tax Code 280E, and make research a lot more feasible.
Rep. Steube filed a similar bill on Sept. 12, 2019, the Marijuana 1-to-3 Act of 2019, which would also downgrade cannabis from schedule 1 to allow for more possibilities in research.
“As marijuana is legalized for medical and recreational use across the United States, it is important that we study the effects of the substance and the potential impacts it can have on various populations,” Congressman Steube said in 2019. “By rescheduling marijuana from a schedule I controlled substance to a schedule III controlled substance, the opportunities for research and study are drastically expanded. With this rescheduling, researchers can now access federal funds to research this substance and determine its medical value.”
The congressman acknowledged that research on cannabis is currently hampered under current conditions.
“We hear every day about the positive health benefits of marijuana. Whether it’s young children with seizure disorders, or veterans suffering from chronic pain, it is clear that there are medical benefits to marijuana and I think it’s time we remove the bureaucratic red tape that prevents us from thoroughly studying this substance,” continued Steube.
The discordant nature of state cannabis laws versus federal law makes such a bill a step, albeit rather small, in the right direction.
President Joe Biden directed an administrative review into the possibilities of rescheduling cannabis under the CSA.
Rep. Steube’s other bills which were announced at the same time as the Marijuana 1-to-3 Act include one that would strip Disney of copyright protections and specifically target what he calls “big tech” and “woke” organizations, per the announcement.
“The Republican majority in the 118th Congress is working to make our government accountable to the people,” said Rep. Steube. “I am reintroducing eight bills that will remove special privileges for Big Tech and woke organizations, cut taxes for Americans and prevent their money from being spent on cruel dog testing, and hold our government accountable while improving efficiency!”
Rep. Streube also takes a controversial stance on other matters such as transgender rights, and pushed to allow guns in airports and add mandatory-minimum sentences for drug trafficking. His 2017 bill would have pushed for stricter sentences for the sale, manufacture, and delivery of cannabis and other drugs.
On Jan. 27 the bill was referred to the Committee on Energy and Commerce, as well as the Committee on the Judiciary, for a period to be determined by the Speaker.
H/T: hightimes.com
